Boston Partners cut its stake in shares of Clarivate PLC (NYSE:CLVT - Free Report) by 96.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 139,566 shares of the company's stock after selling 4,227,785 shares during the quarter. Boston Partners' holdings in Clarivate were worth $548,000 as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. Millstone Evans Group LLC grew its holdings in shares of Clarivate by 156.6% during the first quarter. Millstone Evans Group LLC now owns 7,545 shares of the company's stock valued at $30,000 after purchasing an additional 4,605 shares during the last quarter. Bessemer Group Inc. bought a new position in Clarivate in the 1st quarter worth approximately $30,000. Schonfeld Strategic Advisors LLC bought a new position in Clarivate in the 4th quarter worth approximately $56,000. MQS Management LLC bought a new position in Clarivate in the 1st quarter worth approximately $44,000. Finally, Essex Financial Services Inc. bought a new position in Clarivate in the 1st quarter worth approximately $45,000. 85.72% of the stock is owned by institutional investors.
Insider Activity at Clarivate
In other news, insider James Gordon Samson sold 100,000 shares of the stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $4.53, for a total transaction of $453,000.00. Following the completion of the sale, the insider owned 1,271,103 shares in the company, valued at approximately $5,758,096.59. This represents a 7.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 23.18% of the company's stock.
Wall Street Analysts Forecast Growth
CLVT has been the subject of a number of recent analyst reports. Jefferies Financial Group initiated coverage on Clarivate in a report on Friday, July 18th. They issued a "hold" rating and a $4.50 price objective for the company. Wall Street Zen lowered Clarivate from a "buy" rating to a "hold" rating in a report on Saturday, June 21st. Three analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Reduce" and an average price target of $4.83.
View Our Latest Report on CLVT
Clarivate Price Performance
Shares of NYSE:CLVT traded up $0.0950 on Friday, reaching $4.4950. 5,052,374 shares of the company traded hands, compared to its average volume of 4,842,461. Clarivate PLC has a fifty-two week low of $3.04 and a fifty-two week high of $7.15. The company's 50 day moving average is $4.23 and its 200-day moving average is $4.18. The stock has a market capitalization of $3.02 billion, a PE ratio of -7.25 and a beta of 1.40. The company has a debt-to-equity ratio of 0.90, a current ratio of 0.91 and a quick ratio of 0.91.
Clarivate (NYSE:CLVT - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.18 EPS for the quarter, meeting analysts' consensus estimates of $0.18. Clarivate had a positive return on equity of 8.65% and a negative net margin of 17.33%.The company had revenue of $621.40 million during the quarter, compared to the consensus estimate of $587.17 million. During the same quarter in the prior year, the firm earned $0.20 EPS. The company's quarterly revenue was down 4.4% compared to the same quarter last year. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. As a group, analysts anticipate that Clarivate PLC will post 0.63 earnings per share for the current fiscal year.
Clarivate Company Profile
(
Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Further Reading
Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
